[Asia Economy Reporter Ji Yeon-jin]
▲LG Chem = Application submitted for Phase 3 clinical trial plan in Korea for gout treatment drug (Tigulixostat, LC350189)
▲POSCO Chemical = Regarding reports on pursuing supply of cathode materials worth tens of trillions, "It is true that there was a meeting between the CEOs of the US automaker Ford and POSCO Group, but there were no specific discussions related to cathode material supply."
▲Pharmsco = Decision to merge Pharmsco Food through absorption.
▲EcoPro BM = Q3 sales increased by 283.1% year-on-year to 1,563.2 billion KRW, operating profit increased by 246.3% to 140.9 billion KRW.
▲EcoPro HN = Q3 sales increased by 76.2% year-on-year to 60.6 billion KRW. Operating profit increased by 140.1% to 12.9 billion KRW.
▲EcoPro = Q3 sales increased by 299.5% year-on-year to 1,631.7 billion KRW. Operating profit increased by 356.0% to 210.2 billion KRW.
▲UTECH = Withdrawal of decision for third-party allotment capital increase worth 900 million KRW.
▲GNC Energy = Decision for capital increase worth 23.6 billion KRW for subsidiary Seokmun Green Energy.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
